GRDN stock

Guardian Pharmacy Services, Inc. (GRDN) financials · rev $1.45B

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Guardian Pharmacy Services, Inc. (GRDN) rev $1.45B.

Cached annual income statement
LineFY2025FY2024
Revenue$1.45B$1.23B
Cost of Revenue$1.16B$984.0M
Gross Profit$292.7M$244.4M
Operating Income$72.7M-$62.9M
Net Income$49.2M-$110.0M
Cached annual balance sheet
LineFY2025
Total Assets$412.7M
Current Assets$221.6M
Cash & Equivalents$65.6M
Inventory$43.4M
PP&E$55.5M
Total Liabilities$194.7M
Current Liabilities$160.7M
Long-term DebtN/A
Shareholders' Equity$217.9M
Retained Earnings$66.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$100.3M$58.0M
CapEx$13.4M$14.7M
Investing Cash Flow-$32.2M-$30.4M
Financing Cash Flow-$7.07M-$23.6M
Net Change in Cash$61.0M$3.91M
Free Cash Flow$86.8M$43.3M
These statements as JSON? API free 100/day

FAQ

What is GRDN P/E and revenue?

Guardian Pharmacy Services, Inc. (GRDN) rev $1.45B.

What is GRDN revenue?

Guardian Pharmacy Services, Inc. last cached revenue is $1.45B (FY2025).

Is GRDN profitable?

Guardian Pharmacy Services, Inc. last cached net income is $49.2M (FY2025).

What are GRDN total assets?

Guardian Pharmacy Services, Inc. last cached total assets are $412.7M (FY2025).

What is GRDN free cash flow?

Guardian Pharmacy Services, Inc. last cached free cash flow is $86.8M (FY2025).

Not investment advice. Cached statements, not a live tape.